Posts Tagged ‘obesity care’

Why Are People Quick to Quit GLP-1 Medicines? Is It Surprising?

July 12, 2024 — Reuters has a news flash for us. People are quick to quit taking GLP-1 medicines. In an “exclusive” story, the Reuters report comes from a analysis from Prime Therapeutics and Magellan Rx (Prime/MRx) – a pharmacy benefit manager (PBM). The headline finding is that 85% of people who start on GLP-1 medicines have quit taking […]

Getting Serious About Obesity Care in Medicare

June 27, 2024 — Today for the first time ever, the U.S. House Ways and Means Committee will be marking up the Treat and Reduce Obesity Act on Capitol Hill. This is a big deal simply because it means that finally, after a decade of advocacy efforts, Congress is getting serious about obesity care in Medicare. Technically, what the […]

ADA2024: How Big Is the Problem with Scale for Obesity Care?

June 24, 2024 — One thing is plain to us in the huge showing of interest in obesity at the American Diabetes Association Scientific Sessions (ADA2024). The scale of opportunity is large because the unmet medical need is great. And yet we face a tremendous problem of scale for coping with the need for obesity care. We have problems […]

Evolving Obesity Care: How Do We Get There from Here?

June 14, 2024 — It is unmistakable, Lee Kaplan tells us. Obesity care is evolving. But the change is painfully slow and inadequate – especially in comparison to the rapid advancement in tools for treating obesity. The slow progress is especially painful when you compare it to the progress made against HIV or COVID. In 1984, HIV was almost […]

Marginalizing People with the Greatest Need for Obesity Care

June 3, 2024 — The STOP Obesity Alliance released new data Friday from an exhaustive analysis of access to obesity medicines in Medicaid programs across the United States. It’s not a pretty picture. It gives us more data to show how we are marginalizing people with the greatest need for obesity care. No state fully covered all forms of […]

Bringing Serious Obesity Care Out of Its Little Bubble

May 23, 2024 — “This is a dream come true.” In her opening presentation yesterday to a diverse group of experts in cardiology, endocrinology, and healthcare, the renowned Donna Ryan was marveling at the broad interest surfacing in serious obesity care – reaching far beyond the limited bubble where it stayed for decades. The American College of Cardiology assembled […]

American Heart: Zap the Gap Between Obesity Science and Care

May 21, 2024 — We are witnessing a conversion experience. With the publication of a new policy statement yesterday, the American Heart Association jumped in with both feet to call for closing the gap between obesity science and the typical care that people with obesity receive. Their statement says: “Experts have learned a great deal about the causes of […]

ECO2024: Tailoring and Tapering Obesity Medicines

May 12, 2024 — A pair of studies with semaglutide at ECO2024 in Venice goes straight to the heart of some core questions about advanced obesity medicines. Does everyone need the full, maximum dose to get good results? Will everyone have to keep taking that full dose to keep obesity under control? The answer to both questions is no. […]

Are We Missing Our Chance for Better Equity in Obesity Care?

April 17, 2024 — GLP-1 agonists offer an opportunity to reduce health disparities, writes Karen Kaplan in the Los Angeles Times. But a problem with equity in obesity care is getting in the way. So instead, it seems they may be making things worse. Cardiologist and health services researcher Lauren Eberly tells Kaplan: “These patients have a higher burden […]

Obesity Medicine Wasn’t Born Yesterday, Ya Know

March 27, 2024 — Much of the world is having a revelation. Stat News call is a revolution. So does Oprah. They are waking up to a very basic fact that we’ve been working with for decades now. Obesity is a chronic, treatable disease. Obesity medicine wasn’t born yesterday. But it has, at times, been lonely. Arthur Frank, a […]